GROWTH HORMONE (GH) and insulin-like growth factor-I (IGF-I) play central roles in multiple physiological processes in humans and other mammals. Both proteins are essential for somatic growth, are major contributors to normal tissue regeneration and repair, and are important regulators of intermediary metabolism (26, 34) . Both GH and IGF-I also have been implicated in human aging and in disease, particularly in carcinogenesis (2, 20, 26, 32, 40, 46, 54) , indicating that the activity of these proteins must be limited in scope and duration to maintain physiological homeostasis, and raising the need to devise strategies that enhance their positive physiological actions while limiting their negative impact.
GH and IGF-I have been intimately intertwined for nearly 60 years, ever since the somatomedin hypothesis of GH action postulated the existence of a factor [shown later to be IGF-I (11)] responsible for many of the physiological effects of GH (38) . Subsequent studies have discerned the biochemical relationship between these two proteins. It is now known that GH, acting via its transmembrane receptor, rapidly stimulates IGF-I gene transcription, leading to sustained production of IGF-I mRNAs and synthesis of IGF-I (35) .
Like related cytokine receptors, the GH receptor (GHR) engages the Jak-signal transducer and activator of transcription (Stat) signaling pathway (4) . GH binding induces activation of the receptor-associated tyrosine kinase, Jak2 (3), which phosphorylates tyrosine residues on the intracellular part of GHR (26, 54) , leading to the recruitment of Stat1, -3, -5a, and -5b, as well as other signaling molecules (26, 54) .
The first Stats were characterized over 20 years ago as signaling agents for interferons ␣/␤ and ␥ (41, 42) , and subsequent studies have broadened the biological importance of this protein family in physiology and disease (16, 27, 40, 59) . Stats are typically found in the cytoplasm before cytokine stimulation and are recruited to phosphorylated tyrosine residues on intracellular segments of activated receptors, where they become phosphorylated on a tyrosine near the Stat COOH-terminus by a receptor-linked tyrosine protein kinase, usually Jak1-3 or Tyk2 (16, 27, 40) . After dissociation from the receptor, Stats form dimers via reciprocal interactions of the Src homology 2 domain on one Stat molecule with the phosphorylated tyrosine on another (27) and become translocated into the nucleus, where they bind as dimers to specific DNA sites in chromatin (16, 27, 40, 59) . Most Stats recognize the palindromic DNA sequence, 5=-TTCN x GAA-3= [N is any deoxynucleotide, x ϭ 2-4], but with distinct preferences depending on the individual Stat (12, 27) . For Stat1, -3, and -5, x ϭ 3, and their overall binding profiles are very similar (12) .
Despite the demonstration that multiple signaling pathways act downstream of the GHR (26, 54) , recently identified inactivating molecular lesions in the human STAT5B gene in individuals with impaired growth (19, 24) , targeted knockouts of Stat5b (47, 49, 50) and the GHR in mice (1, 37) , and biochemical and molecular studies (55) , have defined Stat5b as the essential signaling molecule responsible for many of the critical biological actions of GH. For example, IGF-I gene transcription is rapidly and potently induced by GH via Stat5b in rodents (55) , and humans lacking STAT5B have low levels of IGF-I (19) . However, unlike several other genes whose transcription is stimulated by GH through Stat5b, in which critical Stat5b-binding sites are located within the proximal promoters (9, 57) , there are no Stat5b transcriptional response elements near either of the two Igf1 gene promoters. Rather, several GH-inducible Stat5b-binding domains have been mapped throughout human IGF-I and rat and mouse Igf1 gene loci (7, 53, 56) , and some of these elements have been found to possess chromatin properties of transcriptional enhancers (8, 10, 19, 35) .
Here we have sought to determine whether other GHactivated Stats can promote IGF-I gene transcription, and thus potentially contribute to GH-regulated somatic growth. We find that human STAT5A is remarkably similar to STAT5B in its biochemical and functional responses to GH. In contrast, STAT1 and STAT3 show weaker profiles of in vitro binding to Stat DNA elements from the rat Igf1 gene than STAT5B and are less potent than STAT5B in stimulating IGF-I gene transcription through these elements. Taken together, our results offer an explanation for why STAT5B is the key in vivo mediator of GH-activated IGF-I gene transcription and thus GH-regulated somatic growth.
MATERIALS AND METHODS
Materials. Dulbecco's Modified Eagle's Medium (DMEM), fetal bovine serum (FBS), and phosphate-buffered saline were purchased from Mediatech-Cellgro (Herndon, VA). Trypsin-EDTA solution was from Invitrogen (Camarillo, CA). Cos-7 cells (ATCC CRL-1651) were obtained from American Type Cell Culture (Manassas, VA), and recombinant rat growth hormone (GH) was from the National Hormone and Pituitary Program, National Institute of Diabetes and Digestive and Kidney Diseases (Bethesda, MD). Restriction enzymes were purchased from New England Biolabs (Ipswich, MA). Protease inhibitor tabs, polymerases, and ligases were from Roche Applied Sciences (Indianapolis, IN); the 660-nm protein assay reagent was from Pierce Biotechnologies (Rockford, IL); Immobilon-FL PVDF immunoblotting membranes were from Millipore (Billerica, MA); and Hoechst nuclear stain was from Polysciences (Warrington, PA). All primary antibodies were purchased from commercial vendors: Flag M2 and ␣-tubulin, Sigma (St. Louis, MO); Akt, phospho-(p)-tyrosine-100, pSTAT1, and pSTAT3, Cell Signaling (Danvers, MA); STAT1 and STAT3, Transduction Laboratories (Lexington, KY); STAT5A, Santa Cruz Biotechnology (Santa Cruz, CA); STAT5B, Zymed-Life Technologies (Grand Island, NY); and pSTAT5 and CREB, Millipore. Secondary antibodies Alexa Fluor 488 and Alexa Fluor 680 goat anti-mouse IgG were obtained from Invitrogen (Eugene, OR), and secondary antibody goat-anti-rabbit IgG-IR800 was from Rockland Immunochemical (Gilbertsville, PA). DNA, labeled at its 3=-end with Cy5.5, was custom synthesized and HPLC purified by Thermo Fisher Scientific (Rockford, IL) or by the Oregon Health & Science University (OHSU) DNA Services Core. All other chemicals were reagent grade and were purchased from commercial suppliers.
Recombinant plasmids. DNA encoding human STAT1␣ with an in-frame Flag epitope tag at its COOH-terminus was modified from pRC/CMV:STAT1␣-Flag (Addgene, Cambridge, MA) by cloning the insert into pcDNA3 (Invitrogen) via ApaI and NotI restriction sites. DNA for human STAT3 with an in-frame Flag epitope tag at its COOH terminus in pcDNA3 was modified from EF.STAT3DN.Ubc.GFP (Addgene). After the STAT3-Flag cDNA was cloned using HindIII sites into pBluescript (Stratagene, La Jolla, CA), the codon for phenylalanine-703 in STAT3DN was altered to wild-type tyrosine using sitedirected mutagenesis (via Stratagene Quikchange kit), validated by DNA sequencing at the OHSU DNA sequencing core facility, and subsequently cloned into pcDNA3 using XhoI and NotI restriction sites. Flag-tagged human STAT5A in pCMV-SPORT6 was a kind gift from Dr. Vivian Hwa, Oregon Health & Science University. Flag-STAT5A was excised from the plasmid after sequential digestion with XbaI, Klenow fill-in reaction, and digestion with NotI and was cloned into pcDNA3 at PmeI and NotI restriction enzyme sites. Expression plasmids for mouse Jak2, and for chimeric genes encoding the rabbit GH receptor fused to either the Jak2 kinase domain or pseudokinase domain, were kind gifts from Dr. Stuart Frank, University of Alabama Birmingham (58) . The reporter gene pGAS-TA-LUC, which contains two copies of the high-afinity c-sis-inducible element (SIE) cloned 5= to a minimal promoter (48) , was a kind gift from Dr. Olga Timofeeva, Georgetown University. Expression plasmids for human STAT5B and for the mouse GHR in pcDNA3 were described previously (51, 57), as were luciferase reporter plasmids containing rat Igf1 promoter 2 and various enhancer elements (10, 52) .
Cell culture, transient transfections, and reporter gene assays. Cos-7 cells were incubated in antibiotic-free DMEM with 10% FBS at 37°C in humidified air with 5% CO 2 and were transfected with expression plasmids for the mouse GHR or chimeras, for Jak2, and for wild-type STAT1, STAT3, STAT5A, or STAT5B using Transit-LT1 (Mirus Bio LLC, Madison, WI), as described by the supplier. Plasmid quantities transfected per well of a six-well plate were as follows: GHR (300 ng), GHR-Jak2 fusion receptor (300 ng), Jak2 (300 ng), STAT1, STAT5A or STAT5B (600 ng), STAT3 [300 ng (plus 300 ng of pcDNA3)]. The next day cells were incubated in serum-free medium with 2% bovine serum albumin (BSA) for 16 -18 h, followed by addition of rat GH (40 nM ϭ 1,000 ng/ml) or vehicle in the same medium for various times, and whole cell and nuclear protein extracts were prepared, as described (52) . Protein concentrations were determined with the Pierce A660 protein assay. For promoter-reporter assays, Cos-7 cells in 12-well dishes were cotransfected with different expression plasmids and individual promoter-reporter plasmids, as follows: GHR (75 ng), GHR-Jak2 fusion receptor (75 ng), Jak2 (75 ng), STAT1, STAT5A, or STAT5B (150 ng), STAT3 [75 ng (plus 75 ng of pcDNA3)], and luciferase reporter plasmids (125 ng). Later (24 h), cells were incubated for 16 -18 h in serum-free medium and 1% BSA Ϯ rat GH (40 nM). Cells were then harvested, and lysates were used for luciferase assays (10) . Results were normalized to total cellular protein concentrations.
Protein immunoblotting. Protein extracts were separated by SDS-PAGE under denaturing and reducing conditions and transferred to 0.45 M PVDF membranes. Subsequent steps have been described (30) . The following dilutions of antibodies were used: anti-p-tyrosine-100, anti-STAT1, anti-STAT3, anti-pSTAT1, and anti-pSTAT3 at 1:2,000; anti-STAT5A, anti-STAT5B, anti-pSTAT5, anti-Flag, and anti-CREB at 1:4,000; anti-␣-tubulin at 1:10,000; and secondary antibodies at 1:4,000. Images were captured using the LiCoR Odyssey Infrared Imaging System (LiCoR, Lincoln, NE) and version 3.0 analysis software.
Immunocytochemistry. Cos-7 cells in six-well tissue culture dishes were transiently transfected with expression plasmids for the mouse GH receptor or chimeras, for JAK2, and for wild-type STAT1, STAT3, STAT5A, or STAT5B. The next day cells were incubated in serum-free medium with 2% BSA for 16 -18 h, followed by addition of the same medium Ϯ rat GH (40 nM) for 2 h. Cells then were fixed in 4% paraformaldehyde for 15 min at 20°C and permeabilized with a 50:50 mixture of methanol and acetone for 2 min followed by blocking for 2 h at 20°C in 0.25% normal goat serum. After addition of primary antibodies (1:2,000 dilution) in blocking buffer overnight, followed by a washing step, and incubation in Alexa Fluor 488 goat anti-mouse IgG (1:2,000 dilution) in blocking buffer for 2 h, images were obtained with a Nikon Eclipse E800 compound microscope with CCD camera, using Nikon analysis software. Nuclei were stained with Hoescht dye.
DNA-protein binding studies. Electrophoretic gel-mobility shift assays and DNA competition experiments were performed as described (10, 52) with Cos-7 nuclear protein extracts (2 g of protein) and Cy5.5-labeled double-stranded oligonucleotides (5-10 nM). Sequences for the top strand for all double-stranded DNA probes used are listed in Table 1 and, except for the high-affinity SIE element (14), have been described previously (52) , as has the preparation of doublestranded probe DNA (10) . After incubation of proteins and DNA for 60 min at 4°C, products were separated by electrophoresis through nondenaturing 5% polyacrylamide gels in 1ϫ Tris borate/EDTA (90 mM Tris, 90 mM boric acid, 2 mM EDTA, pH 8.3) at 160 volts for 40 min at 4°C. After electrophoresis, bands representing proteinbound DNA and free probe were visualized using the LiCoR Odyssey and version 3.0 analysis software.
Data analysis. Paired and unpaired Student's t-tests were performed using Graphpad Prism 5.0 with Bonferonni corrections used for multiple comparisons.
RESULTS

GH promotes the tyrosine phosphorylation, nuclear translocation, and transcriptional activity of human STAT1, -3, and
-5B. Prior studies have shown that ligand binding to the GHR leads to the activation of multiple intracellular signaling pathways, including those mediated by several Stats in various tissues and cultured cell lines (5, 14, 15, 29, 43) . We have previously reconstituted GH-regulated signaling in Cos-7 cells transiently expressing the mouse GHR and rat Stat5b and have used this approach to dissect the functional and biochemical features of seven distinct regions in the rat Igf1 locus that exhibited acute GH-stimulated binding of Stat5b in hepatic chromatin (10, 52) . Here we use a similar experimental design to assess the properties of human STAT1, STAT3, STAT5A, and STAT5B as mediators of GH action. Coexpression of mouse GHR and STAT5B in Cos-7 cells led to its acute GH-mediated tyrosine phosphorylation (Fig. 1A) . In contrast, GH-stimulated tyrosine phosphorylation of STAT1 or STAT3 was not observed, despite similar levels of production of all three STATs (Fig. 1A) . However, coexpression of mouse Jak2 was able to promote GH-activated tyrosine phosphorylation of STAT1 and STAT3, although it had no further effect on STAT5B (Fig. 1A) . Addition of Jak2 to the GHR also led to comparable levels of nuclear accumulation of each STAT protein in response to GH (Fig. 1B) . In the presence of Jak2, GH stimulated the binding of STAT1 and STAT3 to doublestranded DNA probes, as assessed by in vitro electrophoretic mobility shift experiments with Cos-7 nuclear protein extracts. GH-induced binding was observed to both the high-affinity SIE (14, 15) and to a double-stranded DNA probe composed of rat Igf1 Stat5b element R34 ( Fig. 2A ; see Table 1 for probe sequences).
Functional studies were next performed using as transcriptional reporter genes a recombinant luciferase plasmid containing two copies of the high-affinity SIE element cloned adjacent to a minimal promoter (pGAS-TA-Luc), and a luciferase reporter containing an 80-bp fragment of proximal rat Igf1 promoter 2 and 44 base pairs of adjacent exon 2, plus either one or two copies of the R34 -R35 rat Stat5b element cloned 5= to the promoter. The 2ϫ R34 -35 construct provides an assessment of the transcriptional response to GH that is mediated by combined Stat5b elements. As shown in Fig. 2B , STAT1 or STAT3 were unable to stimulate the luciferase activity of any of the reporters (the increase in activity of the 2ϫ SIEcontaining fusion gene did not reach statistical significance). In contrast, under the same experimental conditions, GH-activated STAT5B was a very effective transcriptional mediator for each of the three reporter plasmids and also was better than STAT1 or STAT3 for SIE-containing pGAS-TA-Luc (Fig.  2B) , even though as seen by in vitro electrophoretic mobility shift assay, the affinity of STAT5B for the SIE was very low (Fig. 2A) .
Maximal stimulation of STAT1 and STAT3 by a GHR-Jak2 fusion receptor enhances their transcriptional activity. When taken together, the results in Figs. 1 and 2 indicated that, even with added Jak2, the overall biological potency of GH-stimulated STAT1 or STAT3 was weaker than STAT5B toward at least one transcriptional response element from the Igf1 gene. To address the possibility that this deficit was still secondary to insufficient activation of STAT1 or -3 by the GHR, we employed a constitutively active chimeric receptor in which the Jak2 kinase domain was fused to the proximal intracellular part 
Core signal transducer and activator of transcription-binding sites are in italics. SIE, c-sis-inducible element.
of the rabbit GHR (58) . When coexpressed with individual STATs into Cos-7 cells, the GHR-Jak2 kinase fusion receptor promoted the robust tyrosine phosphorylation of STAT1, -3, and -5B in the absence of GH (Fig. 3A) and stimulated their DNA-binding activity toward multiple double-stranded probes, as measured by in vitro electrophoretic mobility shift experiments. However, as assessed by competition studies, for most probes tested, the relative DNA-binding affinities of STAT1 and STAT3 were lower than STAT5B (Fig. 3, B and C) . In contrast, a chimeric GHR containing the pseudokinase domain of Jak2 was inactive (Fig. 3B) .
When tested in reporter gene assays, the GHR-Jak2 kinase fusion receptor potently stimulated the ability of STAT1 and -3 to enhance the transcriptional activity of pGAS-TA-Luc compared with GHR plus Jak2 and GH treatment, but had little additional effect on STAT5B (compare Fig. 4 with Fig. 2B ). The chimeric receptor also increased the activity of STAT1 and STAT3 toward other reporter genes containing Igf1 promoter 2, including those encoding Stat5b-binding elements R2-4, R34 -35, R57-59, R60 -61, and 2ϫ R34 -35 (Fig. 4) . For several of these luciferase reporter genes (R2-4, R57-59, R60 -61), the transcriptional potency of STAT1 or STAT3 was equivalent to that of STAT5B (Fig. 4) . Under the same experimental conditions, the GHR-Jak2 pseudokinase domain fusion receptor was ineffective in all cases (Fig. 4) . Taken together, the results in Figs. 3 and 4 suggest that, under the right conditions of sustained activation, STAT1 or STAT3 could possibly stimulate IGF-I gene transcription.
STAT5A and STAT5B are comparable mediators of GH actions. STAT5A and -5B are the most similar of the seven Stats (16, 27) . The human proteins are ϳ96% identical in amino acid sequence and appear to be interchangeable in a number of biological contexts (16) . To test the ability of STAT5A to be activated by GH, we cotransfected it with mouse GHR in Cos-7 cells. Following addition of GH, STAT5A was as rapidly and potently tyrosine phosphorylated as was STAT5B (Fig. 5A) , was detected in the nucleus to an equivalent degree (Fig. 5, B and C) , and was able to bind similarly to several double-stranded DNA probes, as assessed by in vitro electrophoretic mobility shift assays (Fig. 5D ). STAT5A also mediated the robust activation of several reporter genes containing rat Igf1 promoter 2 and individual Stat-binding elements from the rat Igf1 gene, with results being identical to those seen with STAT5B (Fig. 5E) . Thus, STAT5A appears to be as potent a mediator of specific biological effects of GH as STAT5B.
DISCUSSION
The identification of a number of natural mutations in STAT5B in humans with short stature associated with reduced serum IGF-I levels has established that STAT5B is a critical mediator of somatic growth via the GH-IGF-I axis (19, 24) . In parallel, biochemical studies have demonstrated that the hormone-bound GH receptor activates STAT5B via Jak2 (43, 58), a key receptor-associated tyrosine kinase (26, 54) , leading to induction of IGF-I gene transcription (55, 56) , and molecular experiments have shown that STAT5B is both necessary and sufficient for GH-regulated IGF-I gene activation in vivo (55) . Unlike other GH-and STAT5B-dependent genes, IGF-I does not contain any STAT5B response elements in its promoters (9, 10), but, rather, as shown by studies evaluating rat and mouse Igf1 chromatin, it appears that hormone-activated IGF-I gene transcription occurs through recruitment of multiple distinct GH-regulated STAT5B-binding elements with characteristics of long-range transcriptional enhancers (10) .
Here we have sought to determine whether other GHactivated STATs can induce IGF-I gene expression, and thus potentially contribute to the biological effects of GH. Using a combination of biochemical and functional studies, we find that human STAT5A and STAT5B comparably activate GHdependent IGF-I gene transcription, and thus postulate that A: DNA-protein binding was assessed by gel-mobility shift experiments as described in MATERIALS AND METHODS using Cy5.5-labeled double-stranded oligonucleotides for the c-sis-inducible element (SIE) or R34 (see Table 1 for DNA sequences), and 2 g of nuclear protein from Cos-7 cells transfected with expression plasmids for GHR, Jak2, and either STAT1, STAT3, or STAT5B, and incubated Ϯ rat GH (40 nM) for 60 min. FP, free (unbound) probe. The arrows indicate protein-DNA complexes. B: results of luciferase assays in Cos-7 cells transiently transfected with reporter plasmids for the TK promoter plus 2 copies of the SIE element (2ϫ SIE) or containing rat insulin-like growth factor-I (Igf1) promoter 2 and exon 2 and 1 or 2 copies of the R34 -R35 element, and expression plasmids encoding GHR, Jak2, and either STAT1, STAT3, or STAT5B, and incubated Ϯ GH (40 nM) STAT5A could potentially substitute for STAT5B in mediating GH-regulated somatic growth if it were expressed at levels similar to STAT5B in GH-responsive tissues. In contrast, STAT1 and STAT3 are less potent than either STAT5A or STAT5B in stimulating reporter gene activity through STAT DNA elements from the rat Igf1 gene, in part because they show an overall weaker profile of in vitro binding to these DNA segments than STAT5B. Taken together, our results offer a molecular explanation for why STAT5B is a key in vivo mediator of GH-activated IGF-I gene transcription and thus GH-regulated somatic growth.
GHR, Jak2, and STAT activation. Previous experiments in which intracellular domains of the GHR were functionally dissected have suggested that tyrosine residues found in the COOHterminal part of the receptor are needed for maximal GH-stimulated activation of STAT5B in cultured cells (43) (44) (45) , and analogous gene replacement studies in mice have shown that the same distal segment of the GHR mediates maximal GH-induced tyrosine phosphorylation of Stat5b in the liver and is required to promote normal somatic growth (37) . In contrast, more membrane-proximal regions of the GHR were found to mediate maximal hormone-induced activation of STAT1 and -3 (43) (44) (45) , with Jak2 in all cases being the essential tyrosine kinase for these biological actions of the GHR (43).
Additional cell-based studies, using the same chimeric GHR-Jak2 kinase receptors employed here, had found previously that the fusion receptor is a weaker activator of STAT1 and -3 and a far weaker inducer of STAT5B than the intact GHR (58). Our data support a different conclusion, since we find that the chimeric receptor is at least as potent as GHactivated GHR plus Jak2 in stimulating tyrosine phosphorylation of STAT1 and -3, and far more potent in promoting STAT1-and STAT3-dependent gene activation. We also show that the chimeric GHR-Jak2 kinase receptor is a strong stimulator of STAT5B. Possible reasons for the substantial divergence between our results and those of Yi et al. (58) may include technical differences in experimental design, possible distinctions between STATs from different species [we used human STATs, Yi et al. (58) studied mouse Stats], although individual members of this family are highly conserved among mammals (27, 40) , or other more subtle differences. Nevertheless, our data support the idea that the GHR, acting in concert with Jak2, functions as a multivalent signaling transducer, and that multiple STATs can participate in the biological effects of GH.
STAT DNA binding and transcriptional activity. The seven mammalian STATs serve as mediators for overlapping but distinguishable cytokine and growth factor signaling pathways (27, 40) . In addition to preferences for individual receptors and Jaks (27, 40) , STATs also have been found to have distinct DNA-binding profiles (12) . Although all STATs recognize the palindromic double-stranded DNA sequence, 5=-TTCN x GAA-3= [top strand shown, where N is any deoxynucleotide, and x ϭ 2-4 (27, 40)], individual STAT proteins have dramatically different affinities for the same DNA segment, as defined by results of both biochemical and genomic studies (12, 17, 18, 22, 23, 28, 33, 39, 60, 61) . For example, in vitro binding-site selection experiments found small differences between the overall preferences of STAT1 and STAT5 (12) . Both proteins recognized DNA sequences of the type, 5=-TTCN 1 N 2 N 3 GAA-3= (top strand), with STAT1 highly favoring and STAT5 moderately preferring a C in the N 1 position (12) [STAT5A and STAT5B had identical Fig. 3 . Distinct DNA-binding preferences of STAT1, -3, and -5B are maintained after maximal activation by a GH receptor-Jak2 kinase fusion protein.
A: immunoblotting for the Flag epitope, pSTAT1, pSTAT3, and pSTAT5, and for ␣-tubulin reveals comparable stimulation of tyrosine phosphorylation of STAT1, -3, and -5B by a chimeric GHR containing the kinase domain of Jak2. All three STATs are Flag tagged. B: DNA-protein binding was assessed by gel-mobility shift experiments using Cy5.5-labeled double-stranded oligonucleotides for the SIE, R34, and R58 (see Table 1 for DNA sequences), and 2 g of nuclear protein from Cos-7 cells transfected with expression plasmids for the GHR-Jak2 kinase fusion protein (K) or a chimeric protein containing the GHR and the Jak2 pseudokinase domain (P) and either STAT1, STAT3, or STAT5B. Arrows indicate protein-DNA complexes. C: summary of competition DNA-protein binding experiments using the indicated Cy5.5-labeled double-stranded oligonucleotides, 2 g of nuclear protein extracts, and experimental conditions as in B. DNA binding was quantified with a LiCoR Odyssey infrared scanner and version 3.0 analysis software, and relative values assigned as shown. The central 3 nucleotides of the top strand of the 9-bp core Stat-binding site are in bold text. The different flanking nucleotide in the SIE element is in italics. binding profiles (12)]. In contrast, STAT6 strongly preferred 5=-TTCN 1 N 2 N 3 N 4 GAA-3= (top strand) (12) . More recent genomic analyses of STAT DNA binding in chromatin, using ChIP-DNA sequencing approaches, revealed at most minimal differences among STAT1, STAT3, and STAT5 (17, 18, 22, 23, 28, 33, 39, 60, 61) , with slightly higher statistical preferences for STAT1 and STAT3 to bind to DNA with a C in the N 1 and a G in the N 3 position (17, 18, 22, 28, 33, 39) . Importantly, none of these studies have identified a way to accurately predict which DNA elements would bind STAT1 or -3 rather than STAT5A or -5B.
Our results, which have examined the STAT-binding elements identified by ChIP within the rat Igf1 gene (10), agree with these published data, since they do not reveal any clear preferences for specific types of DNA sequences that distinguish among STAT1, -3, or -5B, either by direct in vitro binding studies or indirectly through promoter-reporter gene assays. Moreover, we find at best a modest correlation between in vitro binding affinity of a specific STAT for a DNA sequence and transcriptional potency in cells. For example, after activation by the chimeric GHR-Jak2 receptor, STAT1 and STAT3 were as effective as STAT5B in stimulating the transcriptional activity of a reporter gene containing rat Igf1 promoter 2 fused to either R2-4, R57-59, or R60 -61 STAT DNA elements, despite the lower in vitro DNA-binding affinity of STAT1 and STAT3 compared with STAT5B for each STAT site within each of the three elements. Similarly, STAT5B was more potent than STAT1 or STAT3 in promoting transcription via the R34 -35 element, despite nearly identical binding by all three proteins to R34 DNA (although binding was weaker for STAT1 or STAT3 than STAT5B at R35).
Identical GH-induced activity of human STAT5A and STAT5B. STAT5A and STAT5B are highly conserved genes that are adjacent to each other on human chromosome 17, and are 96% identical in their amino acid sequences (16) . We find that the ligand-bound GHR promotes a nearly superimposable activation of both proteins in cotransfected Cos-7 cells, leading to comparable high-affinity binding to the same DNA elements, and nearly identical transcriptional activation of reporter genes containing rat Igf1 promoter 2 and any of six different Stat-binding elements from the rat Igf1 gene. Our results extend previous cell-based studies that examined the biochemical features of rat Stat5a and Stat5b and their potential roles as mediators of GH actions (44) , and parallel other published data illustrating that STAT5A and STAT5B play comparable signaling roles for other cytokines (6, 16, 47) . Our observations further suggest that hormones, such as prolactin and leptin, which activate multiple STATs, including STAT5A (13, 21, 25, 31) , could promote IGF-I gene transcription under specific circumstances in selected tissues.
Perspective. GH and IGF-I are pivotal agents in human physiology and disease, and a key scientific and medical challenge is to develop strategies that enhance their positive biological actions on growth, metabolism, and tissue repair (26, 34, 36) while limiting their negative effects on aging and cancer (2, 20, 32, 46) . This will require a fuller understanding of the fundamental mechanisms by which GH controls IGF-I biosynthesis. Here we have defined some of the biochemical features that distinguish how STAT5B (or potentially STAT5A) can function as a potent mediator of GH-induced IGF-I gene transcription while STAT1 or STAT3 cannot. Further studies employing chromatin-based transcriptional systems and other experimental models should help pinpoint the unique aspects of STAT5B that are responsible for its critical and distinctive role in the biology of GH and IGF-I. Fig. 4 . Distinct transcriptional profiles of STAT1, -3, and -5B assessed using Igf1 Stat-binding elements. Results of luciferase assays in Cos-7 cells transiently transfected with reporter plasmids for the TK promoter plus 2 copies of the SIE element (2ϫ SIE) or containing rat Igf1 promoter 2 and exon 2 and the indicated Stat-binding elements. Cells also were cotransfected with expression plasmids encoding the GHR-Jak2 kinase fusion protein (GHR-Jak2 K) or a chimera containing the GHR and the Jak2 pseudokinase domain (GHR-Jak2 P), and either human STAT1, STAT3, or STAT5B. Results represent means Ϯ SE of 4 -6 independent experiments, each performed in duplicate. Raw luciferase values for the 2ϫ SIE reporter plasmid in the presence of the GHR-Jak2 P fusion protein ranged from 3,200 to 10,900 light units/10 s. Luciferase values in cells transfected without any STAT plasmid were less than measured in cells expressing the GH-Jak2 P fusion protein. Except where indicated, all reporter gene results were statistically significant (P Ͻ 0.03 to P Ͻ 0.0001, paired t-test) when comparing cells expressing GHR-Jak2 K vs. GHR-Jak2 P. For cells expressing GHR-Jak2 K: *P Ͻ 0.02, STAT5B vs. STAT1 or STAT3 (paired t-test) (ns, not statistically significant).
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